Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Association of prescription abandonment with cost share for high-cost specialty pharmacy medicationsPatrick P Gleason, Catherine I Starner, Brent W Gunderson, et al.Journal of Managed Care Pharmacy : JMCP|December 5, 2012
Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?Alexandra Tungol, Catherine I Starner, Brent W Gunderson, et al.Health Affairs (Project Hope)|October 8, 2014
Specialty drug coupons lower out-of-pocket costs and may improve adherence at the risk of increasing premiumsCatherine I Starner, G Caleb Alexander, Kevin Bowen, et al.Journal of Managed Care Pharmacy : JMCP|August 23, 2013
Health plan utilization and costs of specialty drugs within 4 chronic conditionsPatrick P Gleason, G Caleb Alexander, Catherine I Starner, et al.Pharmacotherapy|January 17, 2002
The emerging role of atypical pathogens in community-acquired pneumoniaPatrick P GleasonJournal of Managed Care Pharmacy : JMCP|May 9, 2009
Critical review of prasugrel for formulary decision makersJeremy A Schafer, Nicole K Kjesbo, Patrick P GleasonCardiovascular Therapeutics|January 16, 2010
Dronedarone: current evidence and future questionsJeremy A Schafer, Nicole K Kjesbo, Patrick P GleasonThe Annals of Pharmacotherapy|January 13, 2005
Are incentive-based formularies inversely associated with drug utilization in managed care?Patrick P Gleason, Brent W Gunderson, Kristin R GerickeJournal of Managed Care Pharmacy : JMCP|July 20, 2010
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasisJeremy A Schafer, Nicole K Kjesbo, Patrick P GleasonJournal of Managed Care Pharmacy : JMCP|July 4, 2007
Telithromycin: the perils of hasty adoption and persistence of off-label prescribingPatrick P Gleason, Carol Walters, Alan H Heaton, et al.Pageof 4